Skip to main content

Minocycline News

Related terms: Minocycline Topical

Minocycline Does Not Decrease Geographic Atrophy Enlargement in AMD

MONDAY, March 25, 2024 – Oral minocycline is not associated with a decrease in geographic atrophy (GA) enlargement in patients with age-related macular degeneration (AMD), according to a study...

FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) – Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced tha...

FDA Approves New Formulation of Minocin (minocycline) for Injection

PARSIPPANY, N.J.--(BUSINESS WIRE)--Apr. 20, 2015-- The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection, Acne, Skin Infection, Skin and Structure Infection, Rosacea, Rheumatoid Arthritis

Minocycline patient information at Drugs.com